A Phase 3, Randomised, Double-Blind, Placebo-Controlled Clinical Trial for Adult Evaluation of the Efficacy and Safety of a Sars-Cov-2 Recombinant Spike Rbd Protein Vaccine (Abdala-3 Study)
SSRN Electronic Journal (2022) - Comments
doi: 10.2139/ssrn.4213351  issn: 1556-5068 

Francisco Hernández-Bernal, Maria Del Carmen Ricardo-Cobas, Yenima Martín-Bauta, Ernesto Rodríguez-Martínez, Klaudia Urrutia-Pérez, Karen Urrutia-Pérez, Joel Quintana-Guerra, Zadis Navarro-Rodríguez, Marjoris Piñera-Martínez, José Luis Rodríguez-Reinoso, Cristina Olimpia Chávez-Chong, Idania Baladrón-Castrillo, Grettel Melo-Suárez, Alejandro Batista-Izquierdo, Alexis R. Pupo-Micó, Ricardo L. Mora-Betancourt, Dayamí Soler-Cano, Jacqueline Bizet-Almeida, Maria C. Martínez-Rodríguez, Leonardo Lobaina-Lambert